Sign in Subscribe
5 min read sma20-signal

EverHint – SMA20 × SMA50 Crossover Signals for Jan 15, 2026 – Technology Leads with 9 Setups

45 signals. Technology leads (9). 13 with insider selling. 3 with insider buying. price range $8-$802. RSI 19-91. sectors: Technology (9), Industrials (8), Healthcare (7). full analyst coverage, earnings data, 37.8% have news.

What This Signal Is (Quick)

This strategy detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50):

  • Buy Signal (SMA20_x_SMA50_Buy) - "Golden Cross": SMA(20) crosses above SMA(50) on today's close

    • Short-term momentum (20 days) exceeds medium-term trend (50 days)
    • Bullish trend confirmation with high reliability
    • Ideal for medium-term trend following (4-12 week holding periods)

  • Sell Signal (SMA20_x_SMA50_Sell) - "Death Cross": SMA(20) crosses below SMA(50) on today's close

    • Short-term momentum weakens below medium-term trend
    • Bearish trend confirmation
    • Can signal exit points or trend reversal alerts

Key Characteristics:

  • Uses two SMAs (both simple moving averages) for maximum stability
  • Most stable strategy - fewer signals but highest quality (fewer whipsaws)
  • Better suited for medium-term trends with confirmed momentum
  • Lower risk entries compared to faster EMA-based strategies

Key Criteria:

  • Buy: SMA20 crosses above SMA50

  • Sell: SMA20 crosses below SMA50

  • Minimum ADV: $40M (liquidity filter)

  • Earnings buffer: 7 days pre/post earnings

  • Fresh crossover: Detected on today's close

Holding Period: 2-6 weeks
Risk Level: Medium

How We Ranked Today

Ranked by RSI (lower RSI = more oversold for buy signals)

📊 SMA20 × SMA50 Crossover Signals (Top 15 of 45 total)

Ranked by rsi14:

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 TEAM Atlassian Corporation Technology 128.45 18.8 $-11.4M 14 $0.00 33.7
2 COKE Coca-Cola Consolidated... Consumer Defensive 150.77 27.5 — 34 $0.00 13.1
3 ALL Allstate Corporation (... Financial Services 195.44 30.2 $-5.8M 20 $24.47 51.7
4 BL BlackLine, Inc. Technology 52.43 34.0 — 26 $0.00 3.3
5 PTGX Protagonist Therapeuti... Healthcare 84.75 35.8 — 36 $3.21 5.3
6 RUN Sunrun Inc. Technology 18.26 38.3 $-5.1M 42 $-0.08 4.2
7 GPI Group 1 Automotive, Inc. Consumer Cyclical 397.10 38.7 — 20 $55.73 5.1
8 VCYT Veracyte, Inc. Healthcare 41.00 42.9 $-471K 39 $2.35 3.2
9 BRX Brixmor Property Group... Real Estate 26.07 44.1 — 25 $0.95 8.0
10 AMGN Amgen Inc. Healthcare 330.03 46.6 $-3.2M 19 $24.93 177.7
11 BOOT Boot Barn Holdings, Inc. Consumer Cyclical 187.40 48.4 — 14 $9.36 5.7
12 PCG Pacific Gas & Electric... Utilities 15.78 49.0 — 28 $2.13 34.7
13 PONY Pony AI Inc. Technology 15.87 51.4 — 68 $0.51 6.1
14 CRUS Cirrus Logic, Inc. Technology 123.28 53.8 — 19 $8.01 6.3
15 IESC IES Holdings, Inc. Industrials 432.69 57.0 $-1.0M 19 $29.75 8.6

Field Notes

Sector concentration: Technology (9), Industrials (8), Healthcare (7)

Insider selling: TEAM (Atlassian Corporation, $-11.4M), ALL (Allstate Corporation (The), $-5.8M), AVAV (AeroVironment, Inc., $-367K)

Insider buying: PRGO (Perrigo Company plc, $+106K), LINE (Lineage, Inc., $+3.3M), ARCC (Ares Capital Corporation, $+265K)

Data coverage: 35.6% insider, 100.0% earnings, 100.0% analyst, 37.8% news

Recent Headlines

ALL (Allstate Corporation (The))

  • Steven Cress' Top 10 Stocks For 2026 (source)
  • December 2025 Monthly Release (source)
  • Here's Why Allstate (ALL) is a Strong Growth Stock (source)
  • CoreCap Advisors LLC Lowers Position in The Allstate Corporation $ALL (source)
  • Allstate (ALL) Stock Dips While Market Gains: Key Facts (source)
  • Here's Why Allstate (ALL) is a Strong Value Stock (source)
  • The Allstate Corporation $ALL Shares Sold by Commonwealth Equity Services LLC (source)
  • CX Institutional Sells 24,822 Shares of The Allstate Corporation $ALL (source)

AMGN (Amgen Inc.)

  • Amgen's Weight-Loss Drug Shows Promise With Less Frequent Dosing (source)
  • Amgen (AMGN) Advances While Market Declines: Some Information for Investors (source)
  • Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses (source)
  • Amgen CEO Bob Bradway goes one-on-one with Jim Cramer (source)
  • Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss (source)
  • Ro partners with Amgen to study barriers to obesity care, GLP-1 access (source)
  • These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (source)
  • GRIMES & Co WEALTH MANAGEMENT LLC Trims Position in Amgen Inc. $AMGN (source)
  • Amgen Inc. (AMGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript (source)
  • Amgen says MariTide helped trial patients maintain weight loss (source)
  • Amgen to announce data on obesity drug MariTide at healthcare conference (source)

GPI (Group 1 Automotive, Inc.)

  • Group 1 Automotive Schedules Release of Fourth Quarter and Full Year 2025 Financial Results (source)

IESC (IES Holdings, Inc.)

  • RVT: Small-Cap Stocks Poised To Outperform In 2026 (source)

PTGX (Protagonist Therapeutics, Inc.)

  • Protagonist Therapeutics, Inc. (PTGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript (source)

RUN (Sunrun Inc.)

  • Sunrun (RUN) Just Flashed Golden Cross Signal: Do You Buy? (source)
  • Sunrun (RUN) Recently Broke Out Above the 50-Day Moving Average (source)
  • Wall Street Analysts Believe Sunrun (RUN) Could Rally 28.3%: Here's is How to Trade (source)

TEAM (Atlassian Corporation)

  • Scott Farquhar Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock (source)
  • Michael Cannon-Brookes Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock (source)
  • 2 Undervalued AI Stocks to Buy Before They Soar 105% and 130% in 2026, According to Wall Street Analysts (source)
  • Atlassian stock crashes amid sustained insider sales: is it a buy? (source)
  • Century Lithium Strengthens Team With Appointment Of Dr. Cormac O'laoire As Strategic Advisor (source)
  • Atlassian Announces Date for Second Quarter of Fiscal Year 2026 Financial Results (source)
  • Michael Cannon-Brookes Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock (source)
  • Scott Farquhar Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock (source)

VCYT (Veracyte, Inc.)

  • Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results (source)

Market Context

The VIX at 15.84, down 4.12%, signals low volatility, creating a calmer market environment with muted intraday swings. This setup benefits SMA20/SMA50 strategies, as smoother price action minimizes false crossovers and allows trends to develop more reliably. With fewer disruptions, signals across 45 instances are more likely to reflect genuine momentum shifts rather than noise.

Broad market trends reveal a mixed picture: the S&P 500 down 0.36%, Nasdaq down 0.69%, and Dow up 0.49%. This divergence points to subdued risk appetite, with strength in more defensive areas potentially pressuring growth sectors. SMA20/SMA50 signals, being trend-following, may thrive in this context by confirming uptrends in resilient pockets, but traders should prioritize those aligning with the overall cautious tone to manage drawdown risks.

Technology's dominance among the 45 signals underscores sector rotation dynamics, even amid the Nasdaq's decline. Low volatility supports pursuing these crossovers for trend continuation, yet the Dow's outperformance hints at flows shifting toward stability, warranting caution on tech-heavy signals to avoid rotation-induced reversals.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Technology (9 signals) suggests sector-specific rotation. 3 signals with insider buying adds conviction. 13 signals showing insider selling warrant caution.

Sharing Call-to-Action

📢 If this analysis helped you, feel free to like, share, or subscribe — it helps the channel grow steadily.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

Published by:

Vladimir Shamgin

You might also like...

17
Jan

EverHint - US Congressional Trading Activity — January 12-16, 2026 — Weekly Snapshot

Modest week with 16 transactions across 7 members. Sen. Tuberville's $50-100K AAPL full liquidation leads activity. Mixed tech signals as lawmakers reduce exposure to Apple, Netflix, ServiceNow while adding telecom. Bipartisan portfolio rebalancing dominates.
8 min read
17
Jan

EverHint - Company News & Sentiment — January 17, 2026 — 24-Hour Snapshot

Financial sector leads with 12+ price milestones including Charles Schwab ATH. Micron's $1.8B fab acquisition signals chip capacity expansion. Mixed sentiment as biotech trials show promise while tech sees 52-week lows. Net +18% bullish tilt.
9 min read
16
Jan

EverHint – Momentum Swing — Explosive Volume Breakout Signals for Jan 16, 2026 – Industrials Leads with 3 Setups

12 signals. Industrials leads (3). 8 with insider selling. price range $12-$351. sectors: Industrials (3), Healthcare (3), Financial Services (2). full analyst coverage, earnings data, 41.7% have news.
5 min read
16
Jan

EverHint – SMA20 × SMA50 Crossover Signals for Jan 16, 2026 – Technology Leads with 12 Setups

40 signals. Technology leads (12). 15 with insider selling. 2 with insider buying. price range $9-$2075. RSI 16-90. sectors: Technology (12), Financial Services (7), Consumer Cyclical (5). full analyst coverage, earnings data, 40.0% have news.
4 min read
16
Jan

EverHint – EMA10 × EMA30 Crossover Signals for Jan 16, 2026 – Technology Leads with 13 Setups

71 signals. Technology leads (13). 22 with insider selling. 5 with insider buying. price range $5-$2060. RSI 14-83. sectors: Technology (13), Healthcare (12), Industrials (9). 2 report earnings within 7 days. full analyst coverage, 32.4% have news.
10 min read